Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2020-09-07 Board/Management Inform…
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Lifecare appoints CEO
Board/Management Information Classification · 99% confidence The document explicitly announces the appointment of a new CEO, Joacim Holter, by the board of directors. This content directly relates to changes in senior management personnel. Based on the provided definitions, this aligns perfectly with the 'Board/Management Information' category (Code: MANG). The document length is short (1531 chars), but it is the primary announcement itself, not an announcement *about* a report, so RPA/RNS is not the primary classification.
2020-09-07 English
Lifecare legger i dag frem halvårsrapport for første halvår 2020.
Earnings Release Classification · 99% confidence The document contains summarized financial figures, including 'DRIFTSINNTEKTER' (Operating Income), 'DRIFTSRESULTAT' (Operating Result), and 'ÅRSRESULTAT' (Annual Result), presented in a comparative table format for the period 0-6 2020 versus 2019. This structure strongly suggests an official financial report covering a specific period. Since the period is '0-6 2020' (the first six months of 2020), it represents a comprehensive report for a period shorter than a full year. This aligns best with the definition of an Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it presents detailed line items rather than just highlights, and it is not a 10-K as it covers a half-year period, not the full year. The document length is short, but it contains the core financial data, making it the report itself, not just an announcement of the report. H1 2020
2020-09-01 Norwegian
Lifecare legger i dag frem halvårsrapport for første halvår 2020.
Interim / Quarterly Report Classification · 100% confidence The document provides a balance sheet ('BALANSE') for Lifecare AS for the period 0-6 2020, comparing it to 2019. It contains substantive financial data (assets, liabilities, equity) rather than just an announcement or certification. Since it covers a period shorter than a full fiscal year (a 6-month interim period), it is classified as an Interim/Quarterly Report. H1 2020
2020-09-01 Norwegian
Lifecare legger i dag frem halvårsrapport for første halvår 2020.
Regulatory Filings Classification · 99% confidence The document text explicitly states in the headline: "Lifecare legger i dag frem halvårsrapport for første halvår 2020." (Lifecare presents today the half-year report for the first half of 2020). This clearly indicates the document is a comprehensive financial report covering a period shorter than a year (six months). This aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although the document contains operational updates, the primary context is the presentation of the half-year financial results.
2020-09-01 Norwegian
Semi-annually report 30.06.20
Environmental & Social Information Classification · 99% confidence The document text discusses ongoing development activities, strategic collaborations (with Digital Diagnostics/Digid), regulatory filings for clinical trials (FDA, BfArM for SARS-CoV-2 test), and future plans related to core technology (Sencell glucose measuring). This content is characteristic of a management discussion or an update provided to investors regarding business operations, progress, and regulatory hurdles, rather than a formal financial statement (10-K, IR), a specific transaction announcement (DIV, SHA), or a brief earnings release (ER). It aligns best with the detailed explanation of business trends and outlook provided in a Management Report (MDA). Given the length (under 5,000 characters) and the narrative style focusing on operational progress rather than just financial figures, MDA is the most appropriate classification.
2020-09-01 English
Lifecare legger i dag frem halvårsrapport for første halvår 2020.
Regulatory Filings Classification · 99% confidence The document text explicitly states: "Lifecare legger i dag frem halvårsrapport for første halvår 2020." (Lifecare today presents the half-year report for the first half of 2020). This clearly indicates the release of a comprehensive financial report covering a period shorter than a year (six months). This aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although the document contains business updates, the primary announcement is the release of the half-year financial report itself, making IR the most appropriate classification over a mere Report Publication Announcement (RPA), given the substantial content provided about operations and strategy alongside the announcement.
2020-09-01 Norwegian

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.